A. Aversa et al., Effects of sildenafil (Viagra (TM)) administration on seminal parameters and post-ejaculatory refractory time in normal males, HUM REPR, 15(1), 2000, pp. 131-134
Sildenafil is a specific inhibitor of phosphodiesterase (PDE) type 5 and re
presents a powerful therapy for male erectile dysfunction (ED) of different
aetiology. Recently, sildenafil has been shown to restore erections in tem
porary ED related to the need of semen collection for assisted reproductive
techniques. In this study, we investigated whether sildenafil administrati
on modifies seminal parameters and/or erectile function in normal healthy v
olunteers. In a double-blind, randomized, placebo-controlled, cross-over tw
o period investigation we enrolled 20 healthy male volunteers (mean +/- SE
age 32 +/- 0.5 years). Subjects were not using any medication for the 3 mon
th period prior to the study and were engaged in a stable relationship with
proven fertility, The effects of sildenafil (100 mg) on seminal parameters
and erectile function after audiovisual sexual stimulation were evaluated
by semen analysis and by colour-Duplex ultrasound (the Resistive Index) res
pectively, In all subjects, sildenafil caused no changes in seminal and ere
ction parameters when compared to placebo. Interestingly, sildenafil admini
stration led to a marked reduction of the postejaculatory refractory time (
10.8 +/- 0.9 min versus 2.6 +/- 0.7 min for placebo and sildenafil respecti
vely; P < 0.0001), These results indicate that in normal subjects acute sil
denafil treatment does not modify semen characteristics and has a positive
influence over the resumption of erections following ejaculation in the pre
sence of a continuous erotic stimulus.